Below is a partial list of the companies that
will be presenting at this year's conference

May 27-28, 2015

  * Important note about presenting companies


22nd Century Group Inc.
22nd Century Group Inc. (XXII)
Industry Sector: Healthcare and Life Sciences

22nd Century Group is a plant biotechnology company focused on technology which allows it to increase or decrease the level of nicotine in tobacco plants through genetic engineering and plant breeding. The Company’s mission is to reduce the harm caused by smoking. 22nd Century owns or exclusively controls 128 issued patents plus an additional 52 pending patent applications in 96 countries. The Company’s strong IP position led to a licensing agreement with British American Tobacco (“BAT”), the world’s second largest tobacco company.

Acme United Corporation
Acme United Corporation (ACU)
Industry Sector: Retail and Consumer Products

Acme United Corporation is a leading worldwide supplier of innovative cutting, measuring and safety products to the school, home, office, hardware and industrial markets. Its leading brands include Westcott®, Clauss®, Camillus®, PhysiciansCare ® and Pac Kit®. The Company has had five years of increasing sales and earnings, and has been recognized by Forbes, Business Week , and Fortune as among the fastest growing small companies in the U.S.

ADMA Biologics
ADMA Biologics (ADMA)
Industry Sector: Healthcare and Life Sciences

ADMA is a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-compromised for medical reasons.

ADMA's lead product candidate, RI-002 is a specialty plasma-derived, polyclonal, Intravenous Immune Globulin, or IGIV, derived from human plasma containing naturally occurring polyclonal antibodies (e.g., Streptococcus pneumoniae, H. influenza type B, Cytomegalovirus (CMV), measles, tetanus, etc.) as well as standardized, high levels of antibodies to respiratory syncytial virus (RSV). ADMA is pursuing an indication for the use of this specialty IGIV product for treatment of patients diagnosed with primary immune deficiency diseases, or PIDD. Polyclonal antibodies are proteins that are used by the body's immune system to neutralize microbes, such as bacteria and viruses. Data review indicates that the polyclonal antibodies that are present in RI-002 support the ability of this product to prevent infections in immune-compromised patients. ADMA's analysis of the data from its pivotal Phase III trial demonstrated that RI-002 met the primary endpoint with zero serious bacterial infections (SBI) reported.

Aemetis, Inc.
Aemetis, Inc. (AMTX)
Industry Sector: Energy and Natural Resources

Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in the California Central Valley near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals.

Anavex Life Sciences Corp.
Anavex Life Sciences Corp. (AVXL)
Industry Sector: Healthcare and Life Sciences

Anavex Life Sciences Corp. (OTCQX: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system (CNS) diseases, pain and various types of cancer. The Company’s lead drug candidates, ANAVEX 2-73 and ANAVEX PLUS, the combination of ANAVEX 2-73 and donepezil (Aricept®), are currently being evaluated in a Phase 2a clinical trial for Alzheimer’s disease. ANAVEX 2-73 is an orally available drug candidate that targets sigma-1 and muscarinic receptors and has successfully completed a Phase 1 study with a clean data profile. Preclinical studies demonstrate its potential to halt and/or reverse the course of Alzheimer’s disease. The drug combination, ANAVEX PLUS, produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually. Recent positive preclinical data indicates that ANAVEX 2-73 also exhibits anticonvulsant, anti-amnesic, neuroprotective and anti-depressant properties, indicating its potential to treat additional CNS disorders, including epilepsy and others.

Angionetics, Inc.
Angionetics, Inc.
Industry Sector: Healthcare and Life Sciences

Angionetics is a privately held operating unit of Taxus Cardium Pharmaceuticals Group (Trading Symbol: CRXM). Angionetics is focused exclusively on the development and commercialization of novel DNA-based therapeutics designed to promote the heart’s innate natural capacity to modulate the formation and growth of microvascular circulation to enhance blood flow (perfusion) in patients with a variety of ischemia-driven disease conditions and persistent angina pectoris due to cardiac microvascular insufficiency (CMI), and other cardiovascular disease conditions.

Angionetics’ lead Phase 3 product candidate, Generx® alferminogene tadenovec [Ad5FGF-4], is a first in class, single-dose, disease altering therapeutic specifically targeted to the cardiac micro-vasculature, and designed to endogenously initiate the formation of new biologic structures, to increase the level of micro-vascularity, enhance cardiac perfusion, and improve cardiac performance, as measured by exercise tolerance and the occurrence and severity of myocardial ischemia-driven angina. Angionetics’ product candidates are designed to easily fit within the current practice of medicine, as single-dose treatments, which are administered by interventional cardiologists using standard cardiac catheters, during an approximately one-hour, out-patient, angiogram-like procedure which is conducted in a hospital or medical center.

Angionetics recently announced an international Generx strategic co-development agreement with Dr. Reddy’s Laboratories Ltd. (NYSE: RDY). Angionetics also recently announced an initial equity investment of $3.0 Million for a 15% equity interest to advance the Generx clinical development program.

AstroTech Corporation
AstroTech Corporation (ASTC)
Industry Sector: Industrials

Astrotech Corporation is an Austin, TX based technology company that has evolved from over 30 years in the the human spaceflight Space Shuttle and Department of Defense satellite programs. The company has become a leader in the commercialization of government sponsored advanced space technologies.

1st Detect, Inc. has developed a mass spectrometer that was designed for use on the International Space Station but also revolutionizes the chemical detection and analysis market by delivering laboratory performance mass spectrometry in a small, affordable and portable package. This instrument is useful in the food processing, process control, laboratory, explosive detection and chemical warfare markets.

Astrogenetix Corporation is the results of over $4 Billion spent by NASA over a 25 year period on experiments conducted in sustained microgravity only achieved while orbiting in space. Astrotech designed and flew 1,113 of these experiments and after an extensive review, discovered that microgravity greatly enhanced the discovery of valuable vaccine and therapeutics. The company has completed 12 successful biomarker discovery missions to the International Space Station and have identified a salmonella vaccine candidate while 10 additional discoveries are in the pipeline. NASA has awarded Astrogenetix 26 free flights to the $130 Billion ISS National Laboratory along with full crew support.

Astral Images, Inc. was created to commercialize identified government funded satellite image correction technologies. Along with the acquisition of certain established defect correction technologies first funded by IBM and Kodak, Astral is positioned to be the world leader in the technology required to convert and repair feature films and film based television series to the new digital HDR Ultra-High Definition 4K standards.

Avant Diagnostics
Avant Diagnostics (AVDX)
Industry Sector: Healthcare and Life Sciences

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in first large panel biomarker screening.  Our first test, OvaDx® detects for pre-symptomatic ovarian cancer.   OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Pre-clinical research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma.  Upon FDA 510K approval, Avant Diagnostics intends to sell or license OvaDx® as a diagnostic test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer.

BioLife Solutions
BioLife Solutions (BLFS)
Industry Sector: Healthcare and Life Sciences

BioLife Solutions develops, manufactures and markets biopreservation media and high performance thermal packaging products for cells, tissues, and organs. The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife’s enabling technology provides academic and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.

BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (BRTX)
Industry Sector: Healthcare and Life Sciences

BioRestorative Therapies, Inc. develops products and medical therapies using cell and tissue protocols, primarily involving adult stem cells, including:
  • Disc/Spine Program: Our lead cell therapy candidate, brtxDISC (DiscImplantedStem Cells), is a product formulated from autologous (or person’s own) cultured mesenchymal stem cells (“MSCs”) collected from the patient’s bone marrow. We intend that the product will be used for the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The treatmentinvolves collecting a patient’s own stem cells, culturing and cryopreserving the cells, and then having a physician inject brtxDISC into the patient’s damaged disc in an outpatient procedure. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and potentially face the prospect of surgery.
  • ThermoStem® Program: We are developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (“BAT”). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

BioSculpture Technology, Inc.
BioSculpture Technology, Inc.
Industry Sector: Healthcare and Life Sciences

BioSculpture Technology, Inc. ("BST") is a commercial stage medical device manufacturer developing a patented and prototyped minimally invasive device for the endoscopic removal of visceral or “belly” fat as a new treatment of obesity, metabolic syndrome and type 2 diabetes mellitus. We believe our method and device will save lives, improve life outcomes, and significantly reduce healthcare costs.

BioSig Technologies, Inc.
BioSig Technologies, Inc. (BSGM)
Industry Sector: Healthcare and Life Sciences

BioSig Technologies, Inc. is a medical device company that has developed a proprietary technology platform designed to greatly improve the rapidly growing $3 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran, independent Board of Directors, Los Angeles-based BioSig is preparing to commercialize its PURE EP™ System.

PURE EP is designed to improve outcomes of EP studies and cardiac catheter ablation, shorten ablation procedure times and reduce recurrence rates. It is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making clinical decisions in real-time. PURE EP acquires and displays high-fidelity cardiac signal recordings and provides guidance in identifying ablation targets - areas of tissue to destroy that otherwise create a heart rhythm disturbance; this information is not easily obtained, if at all, from any other EP equipment on the market today.

BioSig will seek FDA 510(k) approval for its PURE EP System.  The Company has already achieved proof of concept validation at UCLA’s EP & Animal Labs. BioSig is collaborating with several of the nation’s most prestigious cardiac arrhythmia centers to develop, refine and, ultimately, commercialize the PURE EP System, including Texas Cardiac Arrhythmia Institute, UCLA Cardiac Arrhythmia Center, U.H. Case Medical Center in Cleveland, William Beaumont Hospital in Michigan, Mount Sinai Medical Center in NY, and Mayo Clinic in Minnesota.

Presenting Company Sponsor

Blue Calypso, Inc.
Blue Calypso, Inc. (BCYP)
Industry Sector: Technology - Media and Internet

Blue Calypso, Inc. develops and delivers mobile engagement and social advocacy solutions for retailers and product manufacturers using its patented portfolio of products including Mobile ADvantage™, KIOSentrix™, DashTAGG® and SocialECHO™. The Company employs its unique platform to connect consumers to brands, drive store traffic, increase shopper spend and shorten the path-to-purchase. The Blue Calypso platform includes extensive big data analytics, tracking consumer engagement such as the spread of shared content, attribution, geo-location and offer redemption. Brands on this platform have key insight into the performance of their content and the sentiment of their customers in real-time. 

Capnia, Inc.
Capnia, Inc. (CAPN)
Industry Sector: Healthcare and Life Sciences

Capnia, Inc. develops and commercializes novel products based on its proprietary technologies for precision metering of gas flow. Capnia's lead product CoSense® is based on the Sensalyze™ Technology Platform. It is a portable, non-invasive device that rapidly and accurately measures carbon monoxide (CO) in exhaled breath. CoSense has 510(k) clearance for sale in the U.S. and has received CE Mark certification for sale in the European Union. CoSense is used for the monitoring of CO from internal sources (such as hemolysis, a dangerous condition in which red blood cells degrade rapidly), as well as external sources (such as CO poisoning and smoke inhalation). The initial target market is newborns with jaundice that are at risk for hemolysis, comprising approximately three million births in the U.S. and European Union. Capnia's proprietary therapeutic technology uses nasal, non-inhaled CO2 and is being evaluated to treat the symptoms of allergies, as well as the trigeminally mediated pain conditions such as cluster headache, trigeminal neuralgia and migraine.

Catasys, Inc.
Catasys, Inc. (CATS)

Industry Sector: Healthcare and Life Sciences

Cell Source, Inc.
Cell Source, Inc. (CLCS)
Industry Sector: Healthcare and Life Sciences

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented "Veto-Cell" technology represents a major breakthrough in immune system management - safe and selective “tolerizing” of immune response.

Cell Source’s technology addresses one of the most fundamental challenges in human immunology: how to tune immune response so that it tolerates specific “desirable” foreign cells while continuing to attack all other potential threats.

Cell Source is currently commercializing this groundbreaking innovation. Potential applications range from facilitating bone marrow and organ transplantation to effectively treating both blood cancers (e.g., Lymphoma) and non-malignant congenital diseases (e.g., Sickle Cell Anemia).

Pending clinical trials aspire to show dramatic improvements in the treatment of lymphoma and leukemia.

Cella Energy
Cella Energy
Industry Sector: Energy and Natural Resources

Cella Energy is an advanced materials and products company that delivers high performance hydrogen based power in aerospace, UAV, automotive and portable energy applications in military and commercial markets. This disruptive technology is based on its proprietary formulation for solid hydrogen storage which is safe, economical and outperforms lithium ion batteries by 3X, and has advantages over compressed hydrogen. Current products being developed with major partners include aircraft electrical power systems to replace carbon based fuels, electric UAV�s with 3X the flight duration of lithium ion batteries, electric vehicle range extenders and light weight battery replacement systems for the military, with future development aimed at extending these applications to consumer markets. Cella Energy is privately owned, headquartered at the Rutherford Appleton Labs in the UK, where the technology was developed, and at the Kennedy Space Center in the US. Cella Energy is no longer pre-revenue, and expects to undertake a further equity raise in 2015 to accelerate developing its technology and products.

Cel-Sci Corp
Cel-Sci Corp (CVM)
Industry Sector: Healthcare and Life Sciences

CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system. Its lead investigational therapy is Multikine (Leukocyte Interleukin, Injection), currently being studied in a pivotal global Phase III clinical trial. Multikine is the first immunotherapeutic agent being developed as a potential first-line treatment for advanced primary head and neck cancer. CEL-SCI is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 hospitalized patients and as a vaccine (CEL-2000) for Rheumatoid Arthritis (currently in preclinical testing) using its LEAPS technology platform. The investigational immunotherapy LEAPS-H1N1-DC treatment involves non-changing regions of H1N1 Pandemic Flu, Avian Flu (H5N1), and the Spanish Flu, as CEL-SCI scientists are very concerned about the possible emergence of a new more virulent hybrid virus through the combination of H1N1 and Avian Flu, or maybe Spanish Flu. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.

Cesca Therapeutics
Cesca Therapeutics (KOOL)
Industry Sector: Healthcare and Life Sciences

Cesca Therapeutics Inc. ( is engaged in the research, development and commercialization of autologous cell - based therapeutics for use in regenerative medicine. The Company is a leader in the develop ment and manufactur e of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. These include:
  • SurgWerks ™ ; proprietary stem cell therapy point - of - care kit s for the treatment of vascular and orthopedic indications that integrate the following indication specific elements :
    • Cell harvesting
    • Cell processing and selection
    • Cell diagnostics
    • Cell delivery
  • CellWerks TM ; a proprietary stem cell laboratory kit for the p rocessing of target cells used in the treatment of oncological and hematological disorders.
  • The AutoXpress ® (AXP) ; a proprietary automated device , along with companion sterile blood processing disposables , for the harvesting of stem cells from cord blood.
  • The MarrowXpress ® (MXP) ; a derivative product of the AXP and its accompanying disposable bag set, for the isolat ion and concentrat ion of stem cells from bone marrow. Self - powered and microprocessor - controlled, the MXP contains flow control optical sensors that volume - reduces blood (RBC’s and plasma) from bone marrow (stem cells) to a user defined volume in 30 minutes while retaining over 90% of mononuclear cells ( MNCs ) .
  • The Res - Q™ 60 (Res - Q) ; a point - of - care system designed for the preparation of cell conc entrates, including stem cells, from bone marrow aspirates and whole blood for platelet rich plasma (PRP).
  • The BioArchive ® System ; an automated cryogenic device, used by cord blood stem cell banks in more than 30 countries , for cryopreserv ation and archivi ng of cord blood stem cell units for transplant.

China Information Technology, Inc.
China Information Technology, Inc. (CNIT)
Industry Sector: Software and Business Services

China Information Technology, Inc. is a leading Internet service company that provides cloud-based platform, exchange, and big data solutions enabling innovation and smart living in the education, health care, new media, finance and transportation sectors in China.

Leveraging its proprietary Cloud-App-Terminal model, CNIT has disrupted the traditional media industry with its innovative "Cloud Nest" big data services. CNIT provides fully integrated smart data platforms to governments, enterprises and urban users. CNIT has also created a robust Internet ecosystem that enables vertical industry applications with cloud media, cloud meeting, Taoping Net, Tao Meeting, Touch One Pass, Healthcare One Pass, Shopping One Pass.

In 2004, Mr. Jianghuai Lin founded CNIT with his team. In 2008, the Company went public on the NASDAQ Stock Market. In 2009, CNIT was selected as one of the “Deloitte Asia Pacific Technology Fast 500”. In 2010, the Company was selected by Forbes as one of “China’s Potential Enterprises 20”. In 2011, the Company was selected as one of the “Forbes China Best Small and Medium Enterprises”. In 2013, CNIT was added to the NASDAQ Golden Dragon China Index. In 2014, the Company launched China’s first integrated cloud platform for industry applications.

Upholding its core values of  “Responsibility and Professionalism” , CNIT will continue to innovate, collaborate, and lead the transformation of the new media industry landscape and create value the society through its proprietary, cutting-edge Cloud-App-Terminal model platform.

ChromaDex Corporation
ChromaDex Corporation (CDXC)
Industry Sector: Healthcare and Life Sciences

ChromaDex® is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model which utilizes its wholly-owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as “phytochemicals”), chemistry and analytical testing services and product regulatory and safety consulting (as Spherix Consulting). The Company provides seamless science-based solutions to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries. 

CounterPath Corporation
CounterPath Corporation (CPAH)
Industry Sector: Technology - Media and Internet

CounterPath Corporation, is an award-winning provider of SIP-based desktop and mobile VoIP software products and solutions. An industry and user favorite, CounterPath’s Bria softphones for desktop and mobile devices, together with the Company’s server applications and Fixed Mobile Convergence (FMC) solutions, enable service providers, OEMs and enterprises large and small around the globe to offer a seamless and unified communications experience across both fixed and mobile networks. Standards-based, cost-effective and reliable, CounterPath’s award-winning solutions power the voice and video calling, messaging, and presence offerings of customers such as Alcatel-Lucent, AT&T, Avaya, BroadSoft, BT, Cisco Systems, GENBAND, Metaswitch Networks, Mitel, NEC, Network Norway, Rogers and Verizon.

CryoPort, Inc.
CryoPort, Inc. (CYRX)
Industry Sector: Retail and Consumer Products

Cryoport provides end-to-end cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. Its competencies range from skilled, total turnkey management of the entire life sciences cold chain logistics process to complex total management solutions for outsourced cold chain logistics. Its packaging, built around its Cryoport Express® liquid nitrogen dry vapor shippers, is validated to maintain a constant -150°C temperature for a 10-plus day dynamic shipment duration. Its information technology boast a Cryoportal™ Logistics Management Platform which manages the entire shipment process, including initial order input, document preparation, customs clearance, integrator/courier management, shipment tracking, issue resolution, and delivery. Cryoport uses recyclable and reusable components providing an environmentally friendly solution. Cryoport solutions can record the "chain of condition" and "chain of custody" for shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes.

Cupcake Digital, Inc.
Cupcake Digital, Inc.
Industry Sector: Technology - Media and Internet

Founded in 2012, Cupcake Digital, Inc. gives kids the opportunity to interact with the characters they love by transforming children’s entertainment properties into award-winning apps. The Company’s apps are consistently top-ranked on the Apple App Store, Amazon Appstore for Android, Google Play and the Barnes & Noble NOOK Store. Cupcake’s licensed IP portfolio includes Wow! Wow! Wubbzy!, Jim Henson’s Fraggle Rock, Strawberry Shortcake, VeggieTales, Yo Gabba Gabba!, Animal Planet, The Smurfs, Sid the Science Kid, Barney, Mike the Knight, Cloudy with a Chance of Meatballs, Puss In Boots, How To Train Your Dragon, Madagascar, Shrek, and Kung Fu Panda.

Presenting Company Sponsor

DataTrak International Inc.
DataTrak International Inc. (DTRK)
Industry Sector: Technology - Media and Internet

DATATRAK is an industry-leading provider of eClinical solutions and services. The DATATRAK ONE® Unified Experience™ platformremove complexities in clinical research, delivering improved data quality, greater patient safety, and time and cost savings. Our Unified eClinical® platform powers all DATATRAK solutions, delivering efficiencies of a single data source, reducing risk. With industry-leading system reliability built for the Cloud, an exceptional User Experience, and a greater value, DATATRAK ONE® Unified Experience™ leads to better site compliance, better data, and ultimately a safer trial.

Diagnostic Lab Corporation
Diagnostic Lab Corporation
Industry Sector: Technology - Media and Internet

Diagnostic Lab Corporation (DLC) is a biotechnology company dedicated to science, safety, and standards in the emerging cannabis sector. DLC is poised to be the market leader in truth-in-labeling, brand identification, and certification in cannabis. DLC has developed cutting edge testing devices and kits, certifications, safe handling protocols, and a revolutionary online patient platform. Currently, there is an overwhelming demand for such solutions. Unlike most emerging companies in the sector, DLC is committed to utilizing science and medicine. Our advisory board of medical doctors and scientists are first in class and are experts within their discipline. DLC’s chairman is Stephen L. Brenner, MD an orthopedic surgeon and wellness physician.

Direct Insite Corp
Direct Insite Corp (DIRI)
Industry Sector: Software and Business Services

Direct Insite™ provides a powerful platform for unified working capital management that facilitates over $160 billion worth of transactions annually between more than 375,000 companies worldwide.  Direct Insite’s clients include IBM, Siemens, BE Aerospace, Saint Gobain, Carlson, and one of the largest financial institutions in the world.  The flagship component of Direct Insite’s unified working capital management platform is PAYBOX™, an innovative receivables automation solution that combines electronic invoicing, online approvals and adjustments, electronic payments, and integration with any legacy accounting, ERP or lockbox system.  PAYBOX™ is primarily sold through banks to corporate users of their treasury management and lockbox services.  Banks and corporations use PAYBOX™ to reduce Days Sales Outstanding, lower costs, and improve straight-through AR posting.

Dot Hill Systems Corp.
Dot Hill Systems Corp. (HILL)
Industry Sector: Technology - Media and Internet

Dot Hill Systems Corp. designs, manufactures and markets a range of software and hardware storage systems for the entry-level and midrange storage markets. We focus on selling through server-based original equipment manufacturers (OEMs), such as Hewlett-Packard, Dell Inc., Lenovo, Advanced Micro Devices, Inc., and Stratus Technologies; as well as into vertical markets, which primarily include media and entertainment, telecommunications, HPC, Digital Image Archive, Big Data Analytics and oil and gas. Our vertical market customers are OEMs who embed our products into their solutions, as well as resellers.

Echo Therapeutics, Inc.
Echo Therapeutics, Inc. (ECTE)
Industry Sector: Healthcare and Life Sciences

Echo Therapeutics, Inc. is developing its non-invasive, wireless continuous glucose monitoring (CGM) system with potential use in the wearable-health consumer market and the diabetes outpatient market. A significant longer-term opportunity may also exist in the hospital setting. Echo has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications.

Emisphere Technologies, Inc.
Emisphere Technologies, Inc. (EMIS)
Industry Sector: Healthcare and Life Sciences

Emisphere Technologies, Inc. is a specialty pharmaceutical company preparing to commence commercial operations. The Company is currently preparing to launch its first prescription product, oral Eligen B12™, in the U.S.  Beyond Eligen B12™, the Company utilizes its proprietary Eligen® Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. 

EyeGate Pharmaceuticals Inc.
EyeGate Pharmaceuticals Inc. (EYEG)
Industry Sector: Healthcare and Life Sciences

EyeGate Pharma is a late-stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye. EyeGate’s technology addresses two of the most prevalent issues in ophthalmic care; the existing lack of patient adherence and patient safety. EyeGate Pharma is committed to advancing their delivery technology and therapeutic candidates with a goal of bringing new, potentially superior treatment options to patients who will most likely benefit.  

Finjan Holdings, Inc.
Finjan Holdings, Inc. (FNJN)
Industry Sector: Technology - Media and Internet

Finjan, founded in 1997, is a technology company committed to investing in and enabling technology innovation. Our early technology innovations and products helped define the state-of-the-art for detecting and deflecting software intrusions and malicious code delivery, over internet and private networks, to devices located at endpoint connections. Beginning with the formation of the company, we have invested considerable time, effort and resources to secure our inventions with US and Foreign patents. As Finjan’s patented technologies have become increasingly relevant across today’s growing security sector, we continue to seek licenses to our patents across the industry. Finjan has successfully licensed its patents to a number of industry players, demonstrated a strong commitment to pursuing unlicensed companies through litigation, resulting in more than $145 million in licensing revenues, to date. The company continues to invest in the security sector and intends to broaden its technology and intellectual property holdings through continued acquisition, investment, and strategic partnerships.

Industry Sector: Technology - Media & Internet

Furlocity is a company founded on the vision of making pet parents’ lives easier by using 21st century technology to access the services pet parents need for their four legged family members. is the result of that vision, as it is the premier pet accommodations website, providing an online technology platform that enables pet owners to search, identify and book trusted pet boarding stays, veterinary services and pet-friendly hotels. Furlocity’s innovative technology simplifies the booking process for pet owners, and ultimately enhances the overall experience for their beloved pets. Furlocity’s online marketplace currently includes top-rated pet boarding facilities and veterinarians in over 105 cities and 30 states, and more than 100,000 pet-friendly hotels across the United States.

Furlocity was founded in San Diego in 2012 by busy ‘pet parents’ who understood the need to establish a more intuitive process for finding safe pet accommodations options. Furlocity was launched to help foster mutually beneficial relationships between pet owners and trusted pet care services providers.

Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd. (GLMD)
Industry Sector: Healthcare and Life Sciences

Galmed is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel, once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its proprietary first-in-class family of synthetic fatty-acid/bile-acid conjugates, or FABACs. Galmed believes that its product candidate, aramchol, has the potential to be a disease modifying treatment for fatty liver disorders, including NASH, which is a chronic disease that Galmed believes constitutes a large unmet medical need.

General Employment Enterprises, Inc.
General Employment Enterprises, Inc. (JOB)
Industry Sector: Software and Business Services

General Employment Enterprises, Inc. (the "Company") was incorporated in the State of Illinois in 1962 and is the successor to employment offices doing business since 1893. The Company provides staffing services through a network of offices located in the United States. The Company operates in two industry segments, providing professional staffing services and solutions and light industrial staffing services through the names of General Employment, Ashley Ellis, Triad and Omni-One. Also, the Company serves the healthcare market through its Scribe Solutions brand by staffing medical scribes to assist medical practices and hospitals with electronic medical record (EMR) management.

GeoVax Labs, Inc.
GeoVax Labs, Inc. (GOVX)
Industry Sector: Healthcare and Life Sciences

GeoVax Labs, Inc. is a clinical-stage vaccine development company. Our lead programs are focused on Ebola virus and HIV. Our vaccine delivery technology generates virus-like particles (VLPs) that are effective at eliciting safe and effective immune responses. All of the clinical trials for our preventive HIV vaccine have been conducted by the HIV Vaccine Trials Network with funding from the NIH. Our proprietary Ebola vaccine technology has been developed internally and our HIV vaccine technology was developed in collaboration with Emory University, the NIH, and the CDC.

Green Jane Inc.
Green Jane Inc.
Industry Sector: Software and Business Services

Green Jane Inc. is a Colorado-based cannabis company that licenses, brands and provides business services to the marijuana industry. The company is comprised of three divisions: Green Jane Services, which helps cultivators maximize production and retailers maximize revenues and margins; Green Mountain Assets, which develops and leases cannabis-capable properties; and Growth Innovations, an in-house venture group that incubates and monetizes products, services and technology that supports Green Jane's business strategy.

Greenwood Hall, Inc.
Greenwood Hall, Inc. (ELRN)
Industry Sector: Technology - Media and Internet

Greenwood Hall provides colleges and universities with solutions that enable them to adapt and grow in a rapidly changing higher education marketplace. Our cloud-based platform provides schools with the comprehensive operating infrastructure they need to recruit, enroll, engage, support, and create enduring relationships with students. By combining strategies, technology, and people resources, Greenwood Hall is able to provide an unparalleled student experience that maximizes student outcomes while setting a new standard for the future of higher education.

Grom Social
Grom Social
Industry Sector: Technology - Media and Internet

After being kicked off of Facebook twice by his parents, Zach Marks envisioned creating a great social media alternative for kids. So, Zach, along with his brothers, sister, and friends of the family, developed the platform and brought the various characters to life. The beta platform of Grom Social was officially launched in November of 2012 as "A Social Network By Kids For Kids™"

Grom Social has many cool features for kids:
  • Connect with friends
  • Chat and join in group discussions
  • Share photos
  • Post status updates and interesting stories
  • Make their own avatar (“Gromatar”) for their profile photo
  • Watch funny videos
  • Play games and more
Zach’s ingenuity, Grom Social’s value proposition, and the Marks family’s generous and active lifestyle, have attracted kids from around the world, as well as industry leaders, to the site.

Grom Social’s Value Proposition
A Safe, Educational, Fun, and Highly Interactive social media experience for kids, ages 5 - 16 Promoting Social Responsibility amongst Members including No Bullying, Saying No to Drugs, and Saying No to Smoking, Promoting Mutual Respect, a Sense of Community, and Giving Back to Others. A Kid-Friendly Environment with 24/7 live-monitoring and Direct Parental Oversight that Mitigates the Risks Found on Other Social Networking Sites., Inc., Inc. (HEWA)
Industry Sector: Technology - Media and Internet, Inc. operates as a virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs, as well as over-the-counter (OTC) medical products in the United States. The company sells a range of prescription drugs; diabetic supplies, including glucometers, lancets, syringes, and test strips; and OTC medications covering a range of conditions from allergy and sinus to pain and fever to smoking cessation aids. It also offers home medical supplies, such as incontinence supplies, first aid kits, and mobility aids; and diet and nutritional products comprising supplements, weight loss aids, and vitamins and minerals. In addition, the company operates as a licensed mail-order pharmacy for sales to 50 states and the District of Columbia. It sells its products directly to the individual consumers of the pharmaceutical and non-pharmaceutical products. The Company is headquartered in Florence, Kentucky.

Hemispherx Biopharma, Inc.
Hemispherx Biopharma, Inc. (HEB)
Industry Sector: Healthcare and Life Sciences

Hemispherx Biopharma, Inc., headquartered in Philadelphia, Pennsylvania, is a biopharmaceutical company dedicated to treating and preventing chronic viral and immune-based disorders through the development and manufacturing of compounds that enhance the natural immune system of the human body.

The Company’s flagship products include Alferon N Injection® and the experimental immunotherapeutics Ampligen®. Its platform technology includes large and small agents for potential treatment of various chronic viral infections.

hopTo Inc.
hopTo Inc. (HPTO)
Industry Sector: Technology - Media and Internet

Founded in its current form in 2012, hopTo Inc. is an innovator of a unique mobile productivity workspace platform. The hopTo mobile solution delivers an unparalleled user experience without compromising enterprise security. hopTo brings a new standard of mobile productivity by enabling individuals to Search, Access, Create, Edit and Share content from their mobile devices, efficiently and effectively, by leveraging any combination of on-premise or cloud stored content, documents and data as well as enterprise applications. The company is based in Campbell, CA.

Innate Immunotherapeutics Ltd
Innate Immunotherapeutics Ltd (IIL)
Industry Sector: Healthcare and Life Sciences

Innate Immunotherapeutics has a Phase 2B drug candidate to treat secondary progressive multiple sclerosis (“SPMS”). There are currently no safe and effective ongoing treatments for this highly disabling form of multiple sclerosis. Completed Phase 1B/2A trials have demonstrated excellent safety and tolerability. Many treated patients have self-reported significant improvements to disabilities caused by their disease.

A placebo controlled Phase 2B efficacy trial is currently enrolling patients in Australia and New Zealand. On completion of this study, mid 2016, the Company intends to partner with ‘big pharma’ to complete approval trials and enter the unmet US$3 billion SPMS market in the US and Europe.

The Company's core technology, a microparticle based immune modulator, has a number of other potential and important therapeutic applications which are being collaboratively evaluated by leading researchers in the US, Australia, Japan, Korea, and Taiwan. Innate Immunotherapeutics has offices in Sydney (Australia), and Auckland (New Zealand) and is listed on the Australian Securities Exchange (ASX) under the ticker "IIL". The Company's stock is currently held about equally by investors in the U.S., Australia, and New Zealand with the major shareholder (19%) being a NY based private investor. In addition, the U.S. National MS Society is the company's sixth largest shareholder.

Innovative Life Sciences Inc.
Innovative Life Sciences Inc.
Industry Sector: Healthcare and Life Sciences

Innovative Life Sciences, Inc. develops and commercializes award winning life sciences solutions using genomics & advanced drug delivery technologies. The Company has diversified global revenue opportunities from technology licensing of OTC and Rx therapeutic products and SaaS-related revenue from clinical genomics offerings.

Innovus Pharmaceuticals, Inc.
Innovus Pharmaceuticals, Inc. (INNV)
Industry Sector: Healthcare and Life Sciences

Innovus Pharmaceuticals, Inc. is an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective non-prescription over-the counter, medicine and consumer care products to improve men’s and women's health and vitality and treat respiratory diseases.

Headquartered in San Diego, Innovus Pharma is an emerging leader in over-the counter consumer products for men's and women’s health and vitality and respiratory diseases, and has a total of five marketed products in this space. The Company’s products include: Zestra® clinically proven to increase arousal and desire in women, EjectDelay® for premature ejaculation, Sensum+® (for sales outside the U.S. only) to treatthe indication of penile sensitivity, Zestra Glide® a low viscosity water based lubricant, Vesele® for increasing blood flow to enhance sexual and mental health and Androferti® to Support Overall Male Reproductive Health and Sperm Quality.

The Company recently announced that it acquired the worldwide rights to the Fluticare(TM) brand (Fluticasone propionate nasal spray) from Novalere FP., Inc. ("Novalere") through a merger allowing the Company to enter the over the counter nasal steroid market .

Interleukin Genetics, Inc.
Interleukin Genetics, Inc. (ILIU)
Industry Sector: Healthcare and Life Sciences

Interleukin Genetics, Inc. develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance.

Invent Ventures, Inc.
Invent Ventures, Inc. (IDEA)

Industry Sector: Technology - Media and Internet

Inventergy Global, Inc.
Inventergy Global, Inc. (INVT)
Industry Sector: Technology - Media and Internet

Inventergy Global, Inc. is a Silicon Valley based intellectual property company dedicated to identifying, acquiring and licensing the patented technologies of market-significant technology leaders. Led by IP industry pioneer and veteran Joe Beyers, the Company utilizes decades of corporate experience, market and technology expertise, as well as industry connections to assist Fortune 500 companies in leveraging the value of their innovations to achieve greater returns. Inventergy creates value for select corporations through the monetization of their IP assets by building on the program that proved to be very successful at Hewlett Packard. Inventergy seeks to realize the appropriate ROI for their innovations. It represents a unique investment opportunity, positioned at the convergence of expertise, execution and assets. The Company has acquired key patent assets from some of the largest technology companies in the world including Huawei, Nokia and Panasonic, and now has a portfolio of more than 760 patent assets globally. Inventergy understands the challenges of leveraging IP assets and also plays a key role in shaping the future of intellectual property industry.

Iveda Solutions
Iveda Solutions (IVDA)
Industry Sector: Technology - Media and Internet

Iveda Solutions enables cloud video surveillance via its Sentir™ Software as a Service (SaaS) video management platform, utilizing proprietary video streaming and Big Data storage technology. Iveda enables a recurring revenue model by licensing Sentir to service providers (e.g., telecoms, ISPs, data centers, cable companies) for plug-and-play cloud video offering to their customers. Iveda Solutions has a SAFETY Act Designation by the Department of Homeland Security as a Qualified Anti-Terrorism Technology provider.

KonaRed Corporation
KonaRed Corporation (KRED)

Industry Sector: Retail & Consumer Products

Lantronix, Inc.
Lantronix, Inc. (LTRX)
Industry Sector: Technology - Media and Internet

Lantronix, Inc. is a specialized networking company providing M2M (machine to machine) and IoT (Internet of Things) solutions. Our products deliver secure connectivity, device management and mobility for today's increasingly connected world. By networking and managing devices and machines that have never before been connected, we enable our customers to realize the possibilities of the Internet of Things. Founded in 1989, Lantronix pioneers robust, intelligent and easy to deploy solutions for mission critical applications in a wide range of industries, including data center, medical, security, industrial, transportation, retail, financial and government. Lantronix is headquartered in Irvine, California, with offices in Europe, Asia and Japan.

LeMaitre Vascular Inc.
LeMaitre Vascular Inc. (LMAT)
Industry Sector: Healthcare and Life Sciences

Lomiko Metals Inc.
Lomiko Metals Inc. (LMRMF)
Industry Sector: Technology - Media and Internet

Lomiko Metals Inc. is a Canada-based, exploration-stage company. It is engaged in the development of technology and minerals for the new green economy. Currently, its mineral properties include the Quatre Milles graphite property and the Vines Lake property. Lomiko also has an option to earn an 80% interest in the La Loutre graphite property through a joint venture agreement with Canada Strategic Metals.

Futhermore, Lpmiko is invested in graphene technologies through Graphene 3D Lab, owning 10.43% (4.4 million shares), a start-up company that would use graphene-enhanced plastic to print electrically conductive materials from a 3D printer. The company filied a provisional patent application for some of its processes in January 2014. On October 23, 2014, Graphene 3D Lab announced it had reached a significant milestone by printing a battery using a 3D printer. On December 3rd, Lomiko entered into its second graphene start-up through investing $200,000 for 40% of Graphene ESD (Energy Storage Devices).

Mantra Venture Group Ltd.
Mantra Venture Group Ltd. (MVTG)
Industry Sector: Energy and Natural Resources

Mantra Venture Group Ltd. is a clean technology incubator that takes innovative emerging technologies and moves them towards commercialization. Through its subsidiaries, Mantra is currently developing two groundbreaking, environmentally beneficial electrochemical technologies ERC (Electro-Reduction of Carbon Dioxide) and MRFC (Mixed-Reactant Fuel Cell).

ERC is a form of “carbon capture and utilization” (CCU) that converts the polluting greenhouse gas carbon dioxide into useful, valuable products including formic acid and formate salts. By utilizing clean electricity, the process offers the potential for an industrial plant to reduce emissions while generating a salable product and a profit.

The MRFC is an unconventional fuel cell that uses a mixture of fuel and oxidant, thereby greatly reducing the complexity and cost of the fuel cell system. Ideal for portable applications, the MRFC is cheaper, lighter, and more compact than conventional fuel cell technologies.

Presenting Company Sponsor

MassRoots, Inc.
MassRoots, Inc. (MASS)

Industry Sector: Technology - Media and Internet

Presenting Company Sponsor

Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS)
Industry Sector: Healthcare and Life Sciences

Milestone Scientific Inc. is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless.

NanoViricides, Inc.
NanoViricides, Inc. (NNVC)
Industry Sector: Healthcare and Life Sciences

NanoViricides, Inc., in a pre-clinical biotech company developing anti-viral drugs to destroy a wide range of viruses in and on the body as well as in the eye. The Company has developed a platform technology, based on the principles of nanotechnology, that enables rapid drug development either in the lab or in the field.

The Company has successfully treated 5000 animals after infection with a wide range of viral diseases. These include all forms of influenza, HIV/AIDS, herpes of the genitals and the eye, adenovirus of the eye, dengue and dengue hemorrhagic fever, rabies and Ebola.

Construction of a new facility and pilot production plant has been completed and Human trials for FluCide®, our drug for complicated influenza in hospitalized patients, is now planned for the first half of 2016.

The Company is well funded and currently actively trades on the NYSE:mkt with a market cap of $150M.

Napco Security Technologies, Inc.
Napco Security Technologies, Inc. (NSSC)

Industry Sector: Industrials

Neostem Inc.
Neostem Inc. (NBS)
Industry Sector: Healthcare and Life Sciences

NeoStem is a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of novel cell based personalized medicine therapeutics that prevent, treat or cure disease. The Company is developing therapies based on three platform technologies (immune-oncology, ischemic repair and immunomodulation) with a lead, late-stage (Phase 3, 2 and 2, respectively) clinical program for each. The combination of a rich therapeutics pipeline and an externally recognized in-house center for cell therapy process development and manufacturing has created an organization with unique capabilities for accelerated and efficient product development.

Nephros, Inc.
Nephros, Inc. (NEPH)
Industry Sector: Healthcare and Life Sciences

Nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. Nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins.

Nephros was founded in 1997, by healthcare professionals affiliated with Columbia University Medical Center, initially to address the needs of chronic renal failure patients.

The company has developed an alternative to current hemodialysis therapy known as Mid-dilution hemodiafiltration (mid-HDF). Nephros’ proprietary blood purification technologies enable mid-HDF to be offered to chronic renal failure patients. Nephros mid-dilution filters remove a range of harmful substances, specifically substances known as middle molecules, which have been linked to conditions such as carpal tunnel syndrome, dialysis related amyloidosis, and degenerative bone disease in chronic renal failure patients.

Nephros has extended its filtration technologies to meet the demand for liquid purification in other areas, in particular water purification. Nephros is currently developing its filter technology in individual water purifiers for military applications.

Net Element, Inc.
Net Element, Inc. (NETE)
Industry Sector: Technology - Media and Internet

Net Element is a payment-as-a-service technology company focused on enabling payments for global commerce. The Company operates a value-added transaction processing division in the US and a mobile payments division in Russia. The Company entered into a binding term sheet to acquire PayOnline, a market leader in online payments in the Russian Federation, Europe and Asia. In 2015 the Company contemplates growth by expanding product offerings and geographic reach organically and through partnerships.

Novogen Limited
Novogen Limited (NVGN)
Industry Sector: Healthcare and Life Sciences

Novogen is a drug development company focused on bringing into the clinic novel therapeutics for degenerative diseases, cancer in particular. The Company has two proprietary drug technology platforms, each targeting novel drug targets within the cell: Super-benzopyrans (SBPs) and anti-tropomyosins (ATMs)

SBP compounds have been created to kill the full range of cells within a tumor, but particularly the cancer stem cells. The ATM compounds target the cytoskeleton of the cancer cell and when used in conjunction with standard anti-cytoskeleton drugs, result in comprehensive and fataldestruction of the cancer cell’s cytoskeleton.Ovarian cancer, colorectal cancer, malignant ascites, prostate cancer, neural cancers (glioblastoma, neuroblasto-ma) and melanoma are the key clinical indications being pursued, with the ultimate objective of employing both technologies as a unified approach to both first-line therapy and salvage therapies.

nUro, Inc.
nUro, Inc.
Industry Sector: Healthcare and Life Sciences

nUro, Inc. arose from the development of viable clinical programs acquired from Medtronic, developed via SBIR funding at Rosellini Scientific, and finalized via the acquisition of Synaptix, a vertically integrated medical device manufacturing company with a CE Marked deep brain stimulator. This 16-channel recording and stimulation platform has been deployed in clinical studies for the treatment of movement disorders and atrial fibrillation. In addition, the Company has developed a wireless version of the device for use in the peripheral nervous system, most notably the posterior tibial nerve for the treatment of urological disorders. nUro, Inc. has now produced and tested its device conforming to good manufacturing practice in its class 10,000 cleanroom. It is in the midst of a number of controlled clinical trials.

NXT-ID, Inc.
Industry Sector: Technology - Media and Internet

NXT-ID, Inc. is a next generation biometric authentication company. Their innovative MobileBio™ solutions mitigate consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching our innovative suite of biometric and encryption solutions that secure consumers’ mobile and online platforms.

OncoSec Medical Incorporated
OncoSec Medical Incorporated (ONCS)
Industry Sector: Healthcare and Life Sciences

OncoSec Medical Inc. is a biopharmaceutical company developing its investigational ImmunoPulse intratumoral cancer immunotherapy. OncoSec Medical's core technology is designed to enhance the local delivery and uptake of DNA IL-12 and other DNA-based immune-targeting agents. Clinical studies of ImmunoPulse have demonstrated an acceptable safety profile and preliminary evidence of anti-tumor activity in the treatment of various skin cancers, as well as the potential to initiate a systemic immune response without the systemic toxicities associated with other treatments. OncoSec's lead program evaluating ImmunoPulse for the treatment of metastatic melanoma is currently in Phase 2 development, and is being conducted in collaboration with several prominent academic medical centers. As the company continues to evaluate ImmunoPulse in its current indications, it is also focused on identifying and developing new immune-targeting agents, investigating additional tumor indications, and evaluating combination-based immunotherapy approaches.

One Horizon
One Horizon (OHGI)
Industry Sector: Technology - Media and Internet

One Horizon developed a proprietary VoIP platform ("Horizon Platform") that enables wireless carriers around the world to provide customized and optimized voice and data services over any mobile, fixed and satellite network through an easy to install mobile App. Its SmartPacket™ technology underlying the Horizon Platform enables greater bandwidth efficiency by reducing IP overhead and optimizing packet flow, delivery and playback. One Horizon targets emerging markets with high population densities, high penetration of mobile phones, congested mobile networks, and high growth in smartphone adoption. In this context, it has formed strategic relationships with local partners in India, Russia and China.

Opexa Therapeutics
Opexa Therapeutics (OPXA)
Industry Sector: Healthcare and Life Sciences

Opexa Therapeutics, Inc. is a publically traded biotechnology company developing personalized immunotherapies with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on Opexa�s proprietary T-cell technology. The Company�s leading therapy candidate, Tcelna�, is a personalized T-cell immunotherapy that is in a Phase IIb clinical development program (the Abili-T trial) for the treatment of Secondary Progressive MS

Patent Properties
Patent Properties (PPRO)
Industry Sector: Technology - Media & Internet

Patent Properties developed and recently introduced The United States Patent Utility�, a subscription-based service that uses proprietary Big Data software to connect the global stockpile of technology improvements and technical experts, represented by the U.S. patent database, with businesses that can put them into commercial uses that help them compete and grow. The Company also owns and seeks to commercialize, license and enforce the unique portfolio of intellectual property developed by inventor and entrepreneur Jay Walker, who serves as the Company's Executive Chairman. Mr. Walker is best known as the founder of and has twice been named by TIME magazine as "one of the top 50 business leaders of the digital age." Mr. Walker currently ranks as the world's 11th most patented living individual, based on U.S. patent issuances according to Wikipedia. Additional information regarding The U.S. Patent Utility can be found at

Industry Sector: Healthcare and Life Sciences

PAXmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and capital efficiency. PAXmed was founded and is led by three successful medical device entrepreneurs. Dr. Lishan Aklog and Dr. Brian deGuzman are prominent Harvard-trained cardiothoracic surgeons and leaders in medical device innovation. Michael Glennon is a medical device industry veteran and former senior executive at market leader in outsourced medical device manufacturing.

PAXmed is built on a disruptive business model conceived, deployed and refined by its principals. Over the past six years, this team has used its capital and time efficient model to build four successful medical device companies, Vortex Medical, Saphena Medical, Kaleidoscope Medical and Cruzar Medical, each funded with a modest single round of venture capital ($1.4 to $3.5 million). Their first company, Vortex Medical, commercialized its revolutionary AngioVac® a mere eighteen months after its inception and was eventually sold to Angiodynamics (NASDAQ:ANGO) for $55+ million. Saphena Medical has also commercialized its next generation endoscopic vessel harvesting device in eighteen months and is poised to capture significant market share and dramatically enhance its value. Kaleidoscope and Cruzar Medical are similarly moving rapidly to commercialization.

Presenting Company Sponsor

PC Connection Inc.
PC Connection Inc. (PCCC)
Industry Sector: Technology - Media and Telecommunications

We are a national solutions provider of a wide range of information technology, or IT, solutions. We help our customers design, enable, manage, and service their IT environments. We provide IT products, including computer systems, software and peripheral equipment, networking communications, and other products and accessories that we purchase from manufacturers, distributors, and other suppliers. We also offer services involving design, configuration, and implementation of IT solutions. These services are perfom1ed by our personnel and by third-party providers. We have three operating segments, which serve primarily: (a) small- to medium-sized businesses, or SMBs, in our SMB segment, through our PC Connection Sales subsidiary, (b) large enterprise customers, in our Large Account segment, through our MoreDirect subsidiary, and (c) federal, state, and local government and educational institutions, in our Public Sector segment, through our GovConnection subsidiary. We generate sales through (i) outbound telemarketing and field sales contacts by sales representatives focused on the business, educational, healthcare, and government markets, (ii) our websites, and (iii) inbound calls from customers responding to our catalogs and other advertising media. We offer a broad selection of over 300,000 products at competitive prices, including products from Apple, Cisco Systems, Dell, EMC, Hewlett Packard, IBM, Lenovo, Microsoft, Symantec, VMWare, and we partner with more than 1,600 suppliers. Our most frequently ordered products are carried in inventory and are typically shipped to customers the same day the order is received.

Perma-Fix Enviornmental Services Inc.
Perma-Fix Enviornmental Services Inc. (PESI)
Industry Sector: Industrials

Perma-Fix Environmental Services, Inc. is a nuclear services company and leading provider of nuclear and mixed waste management services. The Company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the DOE, the Department of Defense ("DOD"), and the commercial nuclear industry. The Company’s nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to our clients. The Company operates four nuclear waste treatment facilities and provides nuclear services at DOE, DOD, and commercial facilities nationwide.

PlasmaTech Biopharmaceuticals
PlasmaTech Biopharmaceuticals (PTBI)
Industry Sector: Healthcare and Life Sciences

PlasmaTech Biopharmaceuticals, Inc. is a biopharmaceutical company focused on advancing targeted treatments for significant unmet needs of critical patient care. Exploiting two distinct proprietary platforms, PlasmaTech Bio is active in the development and commercialization of cancer supportive care products and plasma-derived therapeutics. The company has a robust product pipeline that includes: a novel plasma fractionation process, a proven patented drug delivery platform, two commercial stage products and multiple follow-on products in development.

PositiveID Corporation
PositiveID Corporation (PSID)
Industry Sector: Healthcare and Life Sciences

PositiveID Corporation™ develops molecular diagnostic systems that use real-time polymerase chain reaction chemistry for bio-threat detection and rapid medical testing. The Company’s proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security Science & Technology directorate, and $30 million of contract funding. M-BAND continuously and autonomously analyzes air samples to detect biological airborne threats in the form of bacteria, viruses, and toxins. The Company’s Firefly Dx is a point-of-need, handheld system designed to deliver molecular diagnostic results in less than 20 minutes. Firefly Dx is being developed to meet the growing need in healthcare and molecular diagnostics markets for handheld, real-time PCR testing, and thereby enabling hospitals, physicians and other providers to save lives and fight disease. PSID has offices in Delray Beach, Florida and Pleasanton, California.

Potbotics Inc.
Potbotics Inc. (N/A)
Industry Sector: Healthcare and Life Sciences

While others are looking to make marijuana stronger, PotBotics is looking to make it smarter. Our diverse technology offering blends robotics, artificial intelligence, DNA analysis and cannabis research to address the major pain points in the medical marijuana industry, benefiting patients, physicians, cultivators and dispensary owners. Together our three products create an enterprise technology platform for medical marijuana.

PURE Bioscience, Inc.
PURE Bioscience, Inc. (PURE)
Industry Sector: Healthcare and Life Sciences

PURE Bioscience, Inc. is focused on developing and commercializing our proprietary antimicrobial products -- primarily as a food safety solution for the food industry. PURE® Hard Surface disinfectant has begun to generate initial revenues: (a) as part of a controlled sales rollout to the franchisees of the nearly 27,000 SUBWAY® locations in the U.S. and, (b) in sales to food manufacturers/processors. We are in various stages of protocol development/testing with additional restaurant chains and processors. “Protecting Your Brand,” PURE Hard Surface disinfectant is a uniquely effective solution to the health and environmental challenges of pathogen and hygienic control. Initial products are based on patented, stabilized ionic silver, Silver Dihydrogen Citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent manufactured as a liquid and delivered in various concentrations. SDC-based disinfecting and sanitizing products are EPA registered. We are well on our way developing a third revenue channel -- seeking FDA approval for SDC for use in direct food contact. Current resources are primarily focused on providing food safety solutions – and we will continue to license the technology platform for other industries. PURE is headquartered in El Cajon, California (San Diego metropolitan area).

QUSA International, Inc.
QUSA International, Inc.
Industry Sector: Retail and Consumer Products

QUSA's business is comprised of (1) its India based subsidiary (IndiaCo) and (2) the distribution and resale of IndiaCo products in the US and other international markets. QUSA's products for the automotive and engine markets are used to manage engine heat, lower operational costs and reduce harmful emissions in vehicles and any other equipment powered by diesel, gasoline and natural gas. IndiaCo designs, manufactures, and sells surface applied thermal products under the brand name Q-Shield™ to OEMs serving the Indian automotive market and for other industrial applications.

IndiaCo is a Tier 1 supplier to large multinational automotive and engine companies in India and is ranked as one of the top performing suppliers by these large multinationals. QUSA operates in large and growing domestic and international markets. Management believes that government mandated environmental restrictions on harmful emissions will continue to drive the demand for QUSA products worldwide. The automotive market in India is dynamic and growing and is expected to develop into the largest automotive market in the world. QUSA technology is high quality, low cost, and has important competitive advantages. QUSA is a growing and profitable company with a proven business model guided by experienced management in the US and India.

Rainmaker Systems Inc.
Rainmaker Systems Inc. (RMKR)
Industry Sector: Technology - Media and Telecommunications

Rainmaker Systems is a B2B e-Commerce company that helps organizations of all sizes, ranging from Fortune 500 enterprises to small-to-medium-sized businesses, increase training-for-profit revenues and create new revenue streams from their customer base. With its unique approach, Rainmaker Systems delivers proprietary cloud-based e-Commerce technology, global and localized sales-assist agents, allowing customers to discover and monetize untapped revenue opportunities.

RestorGenex (RESX)
Industry Sector: Healthcare and Life Sciences

RestorGenex is a specialty biopharmaceutical company focused on developing a portfolio of first-in-class therapeutic products to treat diseases across the ophthalmologic, oncologic and dermatologic space. RestorGenex’s lead product is a novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in pre-clinical development for glioblastoma multiforme. The current pipeline also includes a “soft” anti-androgen compound for the treatment of acne vulgaris. RestorGenex’s novel inhibition of the PI3K pathway and unique targeting of the androgen receptor show promise in a number of additional diseases, which the Company is evaluating for the purpose of creating safe and effective treatments and innovative therapies.

Revive Therapeutics Ltd.
Revive Therapeutics Ltd. (RVV)
Industry Sector: Healthcare and Life Sciences

Revive Therapeutics Ltd. is a clinical-stage company focused on commercializing treatments for gout (Phase 2a in the U.S.) and orphan drug indications such as Cystinuria, Wilson disease and Rett syndrome.

RiceBran Technologies
RiceBran Technologies (RIBT)
Industry Sector: Healthcare and Life Sciences

RiceBran Technologies is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. Rice Bran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world's most underutilized food sources, into a number of highly nutritious human food ingredient and animal nutrition products. Our target markets are human food ingredients and animal nutrition manufacturers and retailers, as well as natural food, functional food and nutraceutical supplement manufacturers and retailers, both domestically and internationally.

Rightscorp (RIHT)
Industry Sector: Technology - Media and Internet

Rightscorp is a leading provider of monetization services for artists and holders of copyrighted Intellectual Property (IP). The Company's digital loss prevention technology focuses on unauthorized online distribution of content such as music, movies, software, and games and works to ensure that owners and creators are rightfully paid for their IP. Rightscorp implements existing laws to solve copyright infringements by collecting payments from illegally downloaded activities via notifications sent through Internet Service Providers (ISPs). The Company's technology identifies repeat copyright infringers, who are then offered a reasonable settlement option when compared to the legal liability defined in the Digital Millennium Copyrights Act (DMCA). The Institute for Policy Innovation estimates that due to piracy of sound recordings alone, the U.S. economy loses $12.5 billion in total output annually. In September 2014, the Company secured $2.65 million in equity financing to be used for general working capital purposes and to expand automation and accelerate growth.

SANUWAVE Health, Inc.
SANUWAVE Health, Inc. (SNWV)
Industry Sector: Healthcare and Life Sciences

SANUWAVE Health, Inc. is a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body’s normal healing processes and regeneration. SANUWAVE applies its patented PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions. Its lead product candidate for the global wound care market, dermaPACE®, is CE Marked throughout Europe and has device license approval for the treatment of the skin and subcutaneous soft tissue in Canada, Australia and New Zealand. In the U.S., dermaPACE is currently under the FDA’s Premarket Approval (PMA) review process for the treatment of diabetic foot ulcers. In addition, there are license/partnership opportunities for SANUWAVE’s shock wave technology for non-medical uses, including energy.

SG Blocks
SG Blocks (SGBX)
Industry Sector: Industrials

SG Blocks is the premier innovator of commercial and private environments utilizing code-engineered cargo shipping containers. Providing solutions to some of the world's biggest companies and government agencies, SG Blocks offers cost effective container-construction technology that exceeds many standard building code requirements. The Company works with developers, architects, builders and owners to achieve faster execution, stronger high-value buildings, and greener construction.

Sino Mercury Acquisition Corp.
Sino Mercury Acquisition Corp. (SMAC)
Industry Sector: Financial and Asset Management Services

Sino Mercury Acquisition Corp. is a blank check company formed for the purpose of entering into a stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region of the world although we initially intend to focus on target businesses in the People’s Republic of China that operate in the non-traditional financial industry. Sino was incorporated under the laws of Delaware on March 28, 2014. The units from the initial public offering (including the over-allotment option) were sold at an offering price of $10.00 per unit, generating total gross proceeds of $40,801,000.

SITO Mobile
SITO Mobile (SITO)
Industry Sector: Technology - Media & Internet

SITO Mobile Ltd., formerly Single Touch Systems, Inc. is a mobile engagement platform serving businesses, advertisers and brands for the purpose of building brand awareness, loyalty and sales. Through its patented technologies and an easy-to-use platform, the Company provides solutions that combine location-based advertising, SMS capabilities, and voice, to allow brands to communicate seamlessly across all mobile devices in key locations. In July 2014, SITO Mobile acquired DoubleVision Networks, a privately held mobile audience buying and targeting platform. Post the DoubleVision integration, SITO Mobile will now leverage real-time bidding algorithms that dynamically assess the open mobile advertising inventory for its "Followme" product, to deliver a superior ROI for its clients. SITO Mobile has built a strong IP portfolio around reservation-based and ad-supported streaming of digital media. The Company became cash flow positive in the first quarter of FY 2014. SITO Mobile has a new CEO, new lead Director, and a new culture. The Company recently secured $10 million in senior secured debt and $1 million in equity investment for general working capital purposes.

Industry Sector: Technology - Media and Telecommunications

SMTP is a provider of services to facilitate email delivery, with a focus on marketing email delivery, but also supporting bulk and transactional sending, reputation management, compliance auditing, abuse processing and issue resolution. Our services provide customers with the ability to increase the deliverability of email with less time, cost and complexity than handling it themselves. SMTP, Inc. is a dividend-paying, publicly-traded company headquartered in Nashua, NH.

Solar3D, Inc.
Solar3D, Inc. (SLTD)

Industry Sector: Technology - Media and Telecommunications

Stellar Biotechnologies, Inc
Stellar Biotechnologies, Inc (SBOTF)
Industry Sector: Healthcare and Life Sciences

Stellar Biotechnologies, Inc. is a commercialization stage company focused in the immunotherapy arena, with world-leading technology in Keyhole Limpet Hemocyanin (KLH) protein. KLH is an important immune-stimulating molecule widely used as a key active ingredient in many new immunotherapies, and as an injectable product to assess immune response. We are committed to applying our Stellar KLH™ platform to power the growing field of disease-targeting immune therapies.

Stem Cells Inc.
Stem Cells Inc. (STEM)
Industry Sector: Healthcare and Life Sciences

StemCells, Inc. is engaged in the research and development of therapeutics using the Company's proprietary human neural stem cells for treating disorders of the central nervous system. The Company has recently completed enrollment in two Phase I/II clinical trials. One in dry age related macular degeneration and one in spinal cord injury. The Company has reported positive interim results in both of these studies and final top-line results will be available in the middle of 2015. The Company recently initiated a Phase II controlled proof of concept study in cervical spinal cord injuries with the goal of demonstrating improved motor function in the upper extremities including the hands, arms, wrists and shoulders. Interim results from the first open label cohort in the Phase II spinal cord injury study is expected late 2015. In addition, the company plans to initiate a Phase II controlled study in dry age related macular degeneration this quarter.

Stevia First Corporation
Stevia First Corporation (STVF)

Industry Sector: Industrials

Sutor Technology Group Limited
Sutor Technology Group Limited (SUTR)
Industry Sector: Industrials

Sutor is one of the leading China-based manufacturers and distributors of high-end fine finished steel products used by a variety of downstream applications. The Company utilizes a variety of in-house developed processes and technologies to convert steel manufactured by third parties into fine finished steel products, including hot-dip galvanized steel, pre-painted galvanized steel, acid-pickled steel, cold-rolled steel and welded steel pipe products.

Sysorex Global Holdings Corp.
Sysorex Global Holdings Corp. (SYRX)
Industry Sector: Technology - Media and Telecommunications

Sysorex Global Holdings Corp. is a leading provider of Information Technology Support Services for enterprise level IT environments including full life cycle software development, interface, integration, operational support, and IT Network Infrastructure Modernization Services. With over 30 years of operating history, they provide a wide range of consulting, systems engineering, cyber security, data analytics and program management expertise.

Theralase Technologies Inc.
Theralase Technologies Inc. (TLT)
Industry Sector: Healthcare and Life Sciences

Theralase Technologies Inc. (“Theralase®”) in its Therapeutic Laser Technology (“TLT”) Division designs, manufactures and markets patented super-pulsed laser technology indicated for the: elimination of pain, reduction of inflammation and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase’s Photo Dynamic Therapy (“PDT”) Division researches and develops specially designed molecules called Photo Dynamic Compounds (“PDCs”), which are able to localize to cancer cells and then when laser light activated, effectively destroy them.

U.S. Geothermal Inc.
U.S. Geothermal Inc. (HTM)
Industry Sector: Energy and Natural Resources

U.S. Geothermal Inc., is a leading and profitable renewable energy company focused on the development, production and sale of electricity from geothermal energy. The Company is currently operating geothermal power projects at Neal Hot Springs, Oregon, San Emidio, Nevada and Raft River, Idaho for a total power generation capacity of approximately 45 megawatts. The Company has advanced stage development projects at the Geysers, in California, and a second phase project at San Emidio, Nevada and El Ceibillo, located near Guatemala City, Guatemala. Exploration projects include Crescent Valley, Nevada, and Vale, Oregon. U.S. Geothermal’s growth strategy is to reach 200MW’s of production by 2020, through a combination of internal development and strategic acquisitions.

Vault Nano Inc.
Vault Nano Inc.
Industry Sector: Healthcare and Life Sciences

Vault Nano Inc. is to transform the cancer immunotherapy and vaccine space with its unique vault technology. Using an indigenous human protein forming a natural capsule to be used as delivery of small molecules, cytokines and drugs. Today’s most promising cancer immunotherapy candidates are complex in nature and use adaptive immune cells to combat cancers. We target the cancer by changing the paradigm from ex-vivo cell preparation to an in-vivo therapy by mimicking a lymph node signal to recruit the necessary immune cells directly into the cancer for a systemic anti-cancer response. Our ImmunOncology™ therapy attracts tumor infiltrating lymphocytes (TILs) to combat solid tumors, metastasized cancers, and it is ideal in combination with the new checkpoint inhibitors lacking immune system signalling. Cancer Immunotherapy is the beginning of the end for cancer with a potential total annual market size of $35 billion.

Viggle Media, Inc.
Viggle Media, Inc. (VGGL)

Industry Sector: Technology - Media and Telecommunications

VirtualScopics, Inc.
VirtualScopics, Inc. (VSCP)
Industry Sector: Healthcare and Life Sciences

VirtualScopics, Inc. is a leading provider of clinical trial imaging solutions to accelerate drug and medical device development. For risk-averse, time-constrained Clinical Trial Study Teams, Medical Directors and Imaging Scientists who require quality imaging data delivered on-time, within budget and on a consistent basis, VirtualScopics’ clinical trial imaging solutions are an inspired true exception to commonly-accepted services provided by other clinical trial imaging providers. Because of the scientific and operational flexibility and responsiveness they can offer, VirtualScopics’ clinical trial imaging solutions deliver special performance advantages compared to other image service providers that offer common, everyday clinical trial imaging services.

Viscount Systems, Inc.
Viscount Systems, Inc. (VSYS)
Industry Sector: Technology - Media and Internet

Viscount is the leading provider of next generation, IT-centric access control and identity management applications. Viscount’s Freedom application platform allows seamless unification of the physical and digital security worlds by replacing discrete, self-contained systems with an integrated security system that is sophisticated enough to protect today’s critical business assets, and flexible enough to keep up with the evolving IT infrastructures of government and private organizations.

VolitionRx Limited
VolitionRx Limited (VNRX)
Industry Sector: Healthcare and Life Sciences

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The tests are based on the science of Nucleosomics which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.

VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the US and ultimately, worldwide.

Vuzix Corporation
Vuzix Corporation (VUZI)

Industry Sector: Retail and Consumer Products

Vuzix Corporation
Vuzix Corporation (VUZI)
Industry Sector: Retail and Consumer Products

Vuzix is a leading developer and supplier of smart glasses and video eyewear products in the consumer, enterprise and industrial markets. The Company’s products - personal display and wearable computing devices offer users a portable high quality viewing experience that provide solutions for mobility, wearable computing displays and Virtual and Augmented Reality (AR). The Company’s products have won 20 Consumer Electronics Show Innovations awards (including 4 for CES 2015), with select products being the world’s best-innovation in their category. With its origins in defense R&D for next-generation military display solutions, Vuzix became one of the leading personal display suppliers to the U.S. military. In 2012, Vuzix sold its military products division and is now focused on pursuing the consumer and enterprise markets for wearable computing and personal display devices, an industry projected by IMS Research to generate revenues of $6 Billion by 2016. The Company holds 41 patents and 10 additional patents pending.

* Important note about presenting companies

The information contained on this website should not be construed as an endorsement of any entity included herein, is not intended to be used, and cannot be used, for the purpose of promoting, marketing, or recommending to another party any transaction or matter. Neither the information nor the Marcum MicroCap Conference shall constitute an offer or the solicitation of an offer to sell or buy any security. Information about the presenting companies, and information contained on presenting company websites has been prepared by and is the responsibility of each of the individual presenting companies. Marcum has not reviewed such information and does not provide any assurance that such information is accurate or complete.